{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:00:10Z","timestamp":1789660810703,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroent\u00e9rologie Clinique et Biologique"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.gcb.2008.07.007","type":"journal-article","created":{"date-parts":[[2009,1,2]],"date-time":"2009-01-02T09:40:10Z","timestamp":1230889210000},"page":"31-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Prevention of relapse by mesalazine (Pentasa\u00ae) in pediatric Crohn's disease: A multicenter, double-blind, randomized, placebo-controlled trial"],"prefix":"10.1016","volume":"33","author":[{"given":"J.-P.","family":"Cezard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Munck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Mouterde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Morali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lenaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lachaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Turck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Maurage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"Girardet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Belli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lamireau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sarles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"Chouraqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Descos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"Olives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-Y.","family":"Mary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gcb.2008.07.007_bib1","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1136\/gut.35.10.1433","article-title":"Incidence of inflammatory bowel disease in northern France (1988\u20131990)","volume":"35","author":"Gower-Rousseau","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2008.07.007_bib2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/gut.37.6.811","article-title":"Identifying patients with a high risk of relapse in quiescent Crohn's disease","volume":"37","author":"Sahmoud","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2008.07.007_bib3","first-page":"354","article-title":"Maladie de Crohn","volume":"25","author":"C\u00e9zard","year":"2000"},{"key":"10.1016\/j.gcb.2008.07.007_bib4","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/gut.34.7.939","article-title":"Growth and clinical course of children with Crohn's disease","volume":"34","author":"Griffiths","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2008.07.007_bib5","first-page":"11","article-title":"Growth in paediatric Crohn's disease","volume":"58","author":"Cezard","year":"2002","journal-title":"Horm Res"},{"key":"10.1016\/j.gcb.2008.07.007_bib6","first-page":"373","article-title":"Growth failure in pediatric inflammatory bowel disease","volume":"16","author":"Markowitz","year":"1993","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gcb.2008.07.007_bib7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/gut.42.2.188","article-title":"Bone mineral density and nutritional status in children with chronic inflammatory bowel disease","volume":"42","author":"Boot","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2008.07.007_bib8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM198005013021801","article-title":"Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study","volume":"302","author":"Present","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gcb.2008.07.007_bib9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1053\/gast.2000.18144","article-title":"A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease","volume":"119","author":"Markowitz","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2008.07.007_bib10","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM200006013422202","article-title":"A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators","volume":"342","author":"Feagan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gcb.2008.07.007_bib11","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.gcb.2008.07.007_bib12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0016-5085(88)90230-2","article-title":"Chronic intermittent elemental diet improves growth failure in children with Crohn's disease","volume":"94","author":"Belli","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2008.07.007_bib13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/gut.38.4.543","article-title":"Supplementary enteral nutrition maintains remission in paediatric Crohn's disease","volume":"38","author":"Wilschanski","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2008.07.007_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0929-693X(01)00717-5","article-title":"Study of psychological repercussions of 2 modes of treatment of adolescents with Crohn's disease","volume":"9","author":"Gailhoustet","year":"2002","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.gcb.2008.07.007_bib15","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0016-5085(83)80017-1","article-title":"Treatment of Crohn's disease with peroral 5-aminosalicylic acid","volume":"85","author":"Rasmussen","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2008.07.007_bib16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3109\/00365528708991929","article-title":"5-Aminosalicylic acid in the treatment of Crohn's disease. A 16-week double-blind, placebo-controlled, multicentre study with Pentasa","volume":"22","author":"Rasmussen","year":"1987","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gcb.2008.07.007_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000199279","article-title":"Effect of a slow-release 5\u2019-aminosalicylic acid preparation on disease activity in Crohn's disease","volume":"33","author":"Saverymuttu","year":"1986","journal-title":"Digestion"},{"key":"10.1016\/j.gcb.2008.07.007_bib18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0016-5085(93)90411-5","article-title":"Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study","volume":"104","author":"Gendre","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2008.07.007_bib19","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1053\/gast.1997.v113.pm9352848","article-title":"Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables","volume":"113","author":"Camma","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2008.07.007_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.gtc.2004.02.010","article-title":"Mesalamine derivatives in the treatment of Crohn's disease","volume":"33","author":"Harrell","year":"2004","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.gcb.2008.07.007_bib21","first-page":"430A","article-title":"Oral mesalamine (Pentasa) as maintenance treatment in pediatric crohn's disease patients with recently induced remission. A multicenter placebo-controlled study","volume":"22","author":"Cezard","year":"1996","journal-title":"J Ped Gastroenterol Nutr"},{"key":"10.1016\/j.gcb.2008.07.007_bib22","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(80)91577-9","article-title":"Measuring Crohn's disease activity","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.gcb.2008.07.007_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non parametric estimation from imcomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.gcb.2008.07.007_bib24","first-page":"B34","article-title":"Regression models and life-tables","author":"Cox","year":"1972","journal-title":"J R Statist Soc"},{"key":"10.1016\/j.gcb.2008.07.007_bib25","series-title":"Analysis of survival data.","author":"Cox","year":"1984"},{"key":"10.1016\/j.gcb.2008.07.007_bib26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2036.1989.tb00253.x","article-title":"Mesalazine in childhood inflammatory bowel disease","volume":"3","author":"Barden","year":"1989","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gcb.2008.07.007_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00054725-199612000-00001","article-title":"Mesalamine in paediatric inflammatory bowel disease: a 10 year experience","volume":"2","author":"D\u2019Agata","year":"1996","journal-title":"Inflamm Bowel Dis"}],"container-title":["Gastroent\u00e9rologie Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S039983200800479X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S039983200800479X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:46:58Z","timestamp":1759974418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S039983200800479X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S039983200800479X"],"URL":"https:\/\/doi.org\/10.1016\/j.gcb.2008.07.007","relation":{},"ISSN":["0399-8320"],"issn-type":[{"value":"0399-8320","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of relapse by mesalazine (Pentasa\u00ae) in pediatric Crohn's disease: A multicenter, double-blind, randomized, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Gastroent\u00e9rologie Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gcb.2008.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}